Pharmaceutical stability of compounded acetylcholine chloride intraocular solution for intracoronary provocative vasospasm testing - Top-Institutions - MDSpire

Pharmaceutical stability of compounded acetylcholine chloride intraocular solution for intracoronary provocative vasospasm testing

  • By

  • Killian J. McCarthy

  • Ryan Greenhalgh

  • Erica MacDonald

  • Laura Cedro

  • Duane Pinto

  • Margaret Stephan

  • Eric A. Osborn

  • June 3, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical Center

    Boston, MA

    Key Differentiators

    • Ophthalmology

  • #2

    Harvard Medical School
    Harvard Medical School

    Boston, MA

    Key Differentiators

    • Ophthalmology

  • #3

    ARL Bio Pharma
    ARL Bio Pharma

    Lakewood, CO

    Key Differentiators

    • Ophthalmology

  • #4

    Jules Stein Eye Institute, University of California, Los Angeles
    Jules Stein Eye Institute, University of California, Los Angeles

    Los Angeles, CA

    Key Differentiators

    • Ophthalmology

  • #5

    The New York Eye and Ear Infirmary
    The New York Eye and Ear Infirmary

    New York, NY

    Key Differentiators

    • Ophthalmology

Original Source(s)

Pharmaceutical stability of compounded acetylcholine chloride intraocular solution for intracoronary provocative vasospasm testing

  • by Killian J. McCarthy, Ryan Greenhalgh, Erica MacDonald, Laura Cedro, Duane Pinto, Margaret Stephan, Eric A. Osborn

  • June 3, 2026

Related Content

Screening of serum biomarkers for coronary artery calcification using DIA quantitative proteomics and construction of a regression model

Correlation between cardiorespiratory fitness and body composition in individuals with different glucose metabolism statuses

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.